| Literature DB >> 29270518 |
Ryota Matsuzawa1, Keika Hoshi2, Kei Yoneki3, Manae Harada3, Takaaki Watanabe3, Takahiro Shimoda3, Shuhei Yamamoto4, Atsuhiko Matsunaga3.
Abstract
INTRODUCTION: Previous reviews have indicated the effectiveness of exercise in people undergoing hemodialysis. However, these analyses did not take into account whether the subjects were elderly. We performed a systematic review of the effects of exercise training in elderly people undergoing hemodialysis and updated the evidence of exercise for people undergoing hemodialysis by adding recent research data.Entities:
Keywords: dialysis; elderly; exercise; meta-analysis; renal replacement therapy
Year: 2017 PMID: 29270518 PMCID: PMC5733833 DOI: 10.1016/j.ekir.2017.06.008
Source DB: PubMed Journal: Kidney Int Rep ISSN: 2468-0249
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram showing selection of randomized controlled trials.
Characteristics of included studies
| Studies | Location | Mean age (SD), yr | Mean duration of HD (SD), yr | No. of patients | Duration of intervention | Type of intervention | Training program | Intensity of program | Outcomes |
|---|---|---|---|---|---|---|---|---|---|
| Akiba | Japan | Ex: 38.4 (9.5) | Ex: 6.15 (3.9) | Ex: 10 | 3 mo | Cycle ergometer before hemodialysis session (+treatment for anemia) | Aerobic for 20 min using cycle ergometer 3 times per wk | No data | Exercise tolerance (VO2 max) |
| Carmack | USA | All: 44.1 | No data | Ex: 23 | 10 wk | Intradialytic | Aerobic exercise for 20–30 min using cycle ergometer 3 times per wk | No data | Exercise tolerance (VO2 peak) |
| Carney | USA | Ex: 36.1 (3.2) | Ex: 2.5 (0.7) | Ex: 11 | 6 mo | Track walking, bicycle ergometer | Aerobic exercise for 45–60 min using indoor track and bicycle ergometer 3 times per wk | 70%–80% of VO2max | Exercise tolerance (VO2max) |
| Cheema | Australia | All: 62.6 (14.2) | 2.2 | Ex: 24 | 24 wk | Intradialytic | High-intensity progressive resistance training: 2 sets of 8 repetitions of 10 types using weighted ankle cuffs or Thera-Band tubing | Borg scale 15 to 17 | Lower extremity muscle strength |
| Chen | USA | Ex: 71.1(12.6) | Ex: 2.6 (2.6) | Ex: 25 | 24 wk | Intradialytic | Progressive resistance training 2 sets of 8 repetitions of 8 types using ankle weights 2 times per wk | OMNI scale 6 (somewhat hard) out of 10 (extremely hard), equivalent to 60% of a 1-repetition maximum | ADL level |
| de Lima | Brazil | Ex: 49.6 (9.1) | Ex: 5.4 (4.0) | Ex: 11 | 8 wk | Intradialytic | Developed peripheral musculature training using anklets consisting of 3 series of 15 repetitions 3 times per wk | 40% of 1RM | QoL |
| de Lima | Brazil | Ex: 43.1 (13.3) | Ex: 6.4 (4.4) | Ex: 10 | 8 wk | Intradialytic | Progressive ergometric bicycle exercise 20 min 3 times per wk | Modified Borg scale 2–3 | QoL |
| Deligiannis | USA | Ex: 46.4 (13.9) | Ex: 6.5 (5.2) | Ex: 16 | 6 mo | Nonintradialytic | Aerobic and low-weight resistance training for 90 min (including 10-min warm- up using cycle ergometer or treadmill, 50-min intermittent aerobic exercise, and 10-min cool-down) 3 times per wk | 60%–70% of the HRmax | Exercise tolerance (VO2max) |
| DePaul | Canada | Ex: 55 (16) | Ex: 4.2 (4.8) | Ex: 20 | 12 wk | Intradialytic | Aerobic training 20 min 3 times per wk, progressive strength training: 1 set of 10 repetitions; number of sets: 1–3 | Borg scale 13 (“somewhat strong”) | Lower extremity muscle strength |
| Dobsak | France | Ex: 58.2 (7.2) | Ex: 4.1 (2.1) | Ex: 11 | 20 wk | Intradialytic | Progressive ergometric bicycle exercise 20–40 min 3 times per wk | 60% peak workload | Exercise tolerance (peak workload) |
| Dong | USA | Ex: 46.5 (12.1) | Unknown | Ex: 15 | 6 mo | Intradialytic | 3 sets of 12 repetitions of leg press, under supervision of study personnel, within 30 min 3 times per wk | 70% of the 1-RM | Lower extremity muscle strength |
| Giannaki | Cyprus | Ex: 59.2 (11.8) | Ex: 2.0 (1.25) | Ex:12 | 6 mo | Intradialytic | Ex: progressive aerobic exercise training using a recumbent cycle ergometer for 45 min 3 times per wk | Ex: 60%–65% of the patient's maximal exercise capacity (in Watts) | Depression |
| Giannaki | Greece | Ex: 56.4 (12.5) | Ex: 3.9 (1.3) | Ex: 15 | 6 mo | Intradialytic | Progressive aerobic exercise training using a recumbent cycle ergometer 3 times per wk | 60%–65% of the patient's maximal exercise capacity (in Watts) | Depression |
| Goldberg | USA | Ex: 38.5 (15.4) | Ex: 1.9 (1.4) | Ex: 14 | No data | Indoor training | Progressive treadmill walking or jogging 45–60 min included 5–10 min low-intensity walking | Initial training: 50–60 VO2max | Exercise tolerance (VO2max) |
| Goldberg | USA | Ex: 40.0 (14.0) | Ex:1.9 (1.5) | Ex: 13 | 12 mo | Unknown | Endurance training for 45 min (cycling using bicycle ergometer and walking-jogging) | 70%–80% of VO2max | Exercise tolerance (VO2max) |
| Groussard | France | Ex: 66.5 (4.6) | Ex: 36.6 (8.2) | Ex: 8 | 3 mo | Intradialytic | Aerobic exercise consisting of cycling 3 times per wk (5-min warm-up, 15–30 min at a tolerable pace and 5-min cool-down) | 55%–60% of the peak power output | Exercise tolerance (VO2 peak) |
| Guadalupe | Mexico | Ex: 28.5 | Ex: 1.0 | Ex: 30 | 12 wk | Intradialytic | Resistance training 2 times per wk using ankle weights and bands | 500-g weight | Grip strength |
| Johansen | USA | Ex: 54.4 (13.6) | Ex: 2.8 | Ex: 20 | 12 wk | Intradialytic | Progressive resistance training using ankle weights 2–3 sets of 10 repetitions | 60% of 3RM | Lower extremity muscle strength |
| Kirkman | UK | Ex: 48 (18) | Ex: 3.8 (4.5) | Ex: 12 | 12 wk | Intradialytic | Progressive resistance training: 8 sets of 10 repetitions of 10 types using resistance bands 3 times a wk | 3 sets of 8–10 repetitions at 80% of their predicted 1RM with 2-min rest period between sets | Lower extremity muscle strength |
| Koh | Australia | Ex: 52.3 (10.9) | Ex: 2.7 (2.2) | Ex: 15 | 6 mo | Intradialytic | Aerobic exercise training for 30–45 min using cycle ergometer 3 times per wk | Borg scale 12–13 | Grip strength |
| Konstantinidou | Greece | Ex: 46.4 (13.9) | Ex: 6.5 (5.2) | Ex: 16 | 6 mo | Nondialysis days | Aerobic and strengthening training for 60 min 3 times per wk (10 min warm-up, 30 min intermittent aerobic exercise, 10 min stretching, low-weight resistance training and 10 min cool-down) | 60%–70% of the HRmax | Exercise tolerance (VO2 peak) |
| Konstantinidou | Greece | Ex: 48.3 (12.1) | Ex: 6.0 (5.5) | Ex: 10 | 6 mo | Intradialytic | Aerobic and strength training for 60 min program 3 times per wk (30 min with a bed bicycle ergometer and 30 min for strength and flexibility) | 70% of the HRmax | Exercise tolerance (VO2 peak) |
| Koufaki | UK | Ex: 57.3 (14.3) | Ex: 3.1 (3.8) | Ex: 26 | 12 wk | CAPD: in the Renal Rehabilitation Gym | Progressive aerobic training on a cycle ergometer 3 times per wk | 90% of VT | Exercise tolerance (VO2 peak) |
| Kouidi | Greece | Ex: 49.6 (12.1) | Ex: 5.9 (4.9) | Ex: 20 | 6 mo | Nondialysis days | Supervised exercise (stationary cycling, walking or jogging, calisthenics, aerobics, swimming and/or game sports) 90 min 3–4 times per wk | 50%–60% of their VO2max or 60%–70% of their HRmax | Exercise tolerance (VO2max) |
| Kouidi | USA | Ex: 54.6 (8.9) | Ex: 6.3 (3.7) | Ex: 32 | 10 mo | Intradialytic | Supervised training (40 min: cycling ergometer; 30 min: progressive muscle strengthening 3 sets of 15 repetitions using Thera-Band tubing | Borg scale 13 (somewhat hard) | Exercise tolerance (VO2 peak) |
| Matsufuji | Japan | Ex: 69 (61–78) | Ex: 14 | Ex: 12 | 12 wk | On dialysis day | 5 sets chair stand exercise as resistance training | 5 sets of half of the maximum duration for each participant with 4 short breaks | Lower extremity muscle strength |
| Matsumoto | Japan | Ex: 60.8 (9.5) | Ex: 12.4 (6.8) | Ex: 17 | 12 mo | Endurance training before each hemodialysis treatment | 20 min of continuous cycling 3 times per wk | Borg scale 11–13 (60%– 70% of peak heart rate) | QoL |
| Molsted | Denmark | Ex: 59.0 | Ex: 2.0 | Ex: 22 | 5 mo | Unknown | Strength and aerobic exercises for 1 h twice a wk (10 min of warm-up, 20–30 min of strength and aerobic exercises, 20 min of interval cycling, and 10 min cooling down) | Borg scale 14–17 | Exercise tolerance (VO2max) |
| Ouzouni | Greece | Ex: 47.4 (15.7) | Ex: 7.7 (7.0) | Ex: 19 | 10 mo | Intradialytic | 60–90 min 3 times per wk (cycling: 30 min, strengthening: 30 min, flexibility exercise: 30 min) | Borg scale 13–14 (“somewhat hard”) | Exercise tolerance |
| Painter | USA | Ex: 43.5 (10.5) | Ex: 5.0 (6.7) | Ex: 12 | 5 mo | Intradialytic (+ Normalized hematocrit) | Continuous cycling 30 min 3 times per wk | Borg scale 12–14 (70% of peak heart rate) | Exercise tolerance (VO2 peak) |
| Parsons | Canada | Ex: 60.0 (17.0) | Ex: 2.9 (2.1) | Ex: 6 | 8 wk | Intradialytic | Cycle ergometry exercise for 15 min 3 times per wk | 40%–50% maximal work capacity | QoL |
| Pellizzaro | Brazil | Ex: 48.9 (10.1) | Ex: 4.5 | Ex: 14 | 10 wk | Intradialytic | Resistance training using leg weights 3 sets of 15 knee extension repetitions | 50% of 1RM | Walking ability (6MWT) |
| Pellizzaro | Brazil | Ex: 43.0 (13.8) | Ex: 5.0 | Ex: 11 | 10 weeks | Intradialytic | Inspiratory muscle training using the | 50% of PImax | Walking ability (6MWT) |
| Petraki | Greece | Ex: 50.05 (13.2) | Ex: 6.4 (0.6) | Ex: 22 | 7 mo | Intradialytic | Progressive 60 min cycling using specific bed cycles (including 5-min warm -up and terminated 5-min recovery) and 30 min strengthening and flexibility exercises 3 times per wk | Borg scale 13 | Exercise tolerance (VO2 peak) |
| Reboredo | Brazil | Ex: 50.7 (10.7) | Ex: 3.3 (3.4) | Ex: 12 | 12 wk | Intradialytic | Warmed up for 10 min (lower-limb stretching exercise, low work rate cycling) | No data | Exercise tolerance (VO2 peak) |
| Reboredo | Brazil | Ex: 50.7 (10.7) | Ex: 3.3 (3.4) | Ex: 12 | 12 wk | Intradialytic | Aerobic exercise at moderate exertion for 43 min 3 times per wk (10 min warm-up by lower limb stretching, 5 min low-intensity cycling, 35 min moderate intensity cycling, and 3 min cool-down) | Modified Borg scale 4–6 | Exercise tolerance (VO2 peak) |
| Segura-Orti | Spain | Ex: 53.5 (18.0) | Ex: 3.1 (2.9) | Ex: 17 | 24 wk | Intradialytic | Progressive resistance training that targeted major muscle groups of lower extremities, 3 sets of 4 exercises using weights and elastic bands | Borg scale 12–15 | Exercise tolerance (VO2 peak) |
| Song | Korea | Ex: 52.1 (12.4) | Ex: 3.2 (2.2) | Ex: 20 | 12 wk | Predialysis resistance training | 5 min warm-up and cool-down; progressive resistance training consisted of upper and lower body exercise using elastic bands and sandbags for 30 min 3 times per wk | Borg Scale 11–15 (moderate to hard) | Grip strength |
| Tsuyuki | Japan | Ex: 40.1 (11.9) | Ex: 2.1 (2.5) | Ex:17 | 20 wk | Nondialysis days | Combination training of bicycle ergometry, walking, and jogging for 30 min 2–3 times per wk | 50%–60% of the peak heart rate | Exercise tolerance (VO2 peak) |
| van Vilsteren | Netherlands | Ex: 52 (15) | Ex: 3.2 (4.1) | Ex: 53 | 12 wk | Predialysis strength training | A 5- to 10-min warm-up and cool-down; a 20-min exercise program including calisthenics, steps, flexibility, and low weight resistance training | Borg scale 12–16 | Exercise tolerance (VO2 peak) |
| Wilund | USA | Ex: 60.8 (3.2) | Ex: 5.3 (8.7) | Ex: 7 | 4 months | Intradialytic | Endurance exercise training for 45 min using cycle ergometer 3 times per wk | Borg scale 12–14 | Walking ability (shuttle walk test) |
| Wu | China | Ex: 45 | Ex: 4.6 (3.1) | Ex: 32 | 12 weeks | Intradialytic | 15–20 min of recumbent cycling (including 5-min warm-up) | Energy consumption of 70–100 calories, Borg scale 12–16 and an increase in heart rate of 20 beats/min (optimum individualized exercise load) | Grip strength |
ADL, activities of daily living; Con, control; CT, computed tomography; DEXA, dual-energy x-ray absorptiometry; Ex, exercise; HD, hemodialysis; HRmax, maximum heart rate; MRI, magnetic resonance imaging; PImax, maximum inspiratory pressure; RM, repetition maximum; QoL, quality of life; SPPB, short physical performance battery; STS, sit-to-stand; TUG, timed up & go test; VO2max, maximum oxygen consumption; VT, ventilatory threshold; 6MWT, 6-minute walk test.
Thera-Band tubing is manufactured by Performance Health (Akron, OH).
Figure 2Forest plot showing the effects of supervised exercise training compared with usual care on changes in exercise tolerance (peak/maximum oxygen consumption). CI, confidence interval; IV, inverse variance; Std., standard.
Figure 3Forest plot showing the effects of supervised exercise training compared with usual care on changes in walking ability (6-minute walking distance). CI, confidence interval; IV, inverse variance; Std., standard.
Figure 4Forest plot showing the effects of supervised exercise training compared with usual care on changes in muscle strength (lower-extremity muscle strength). CI, confidence interval; IV, inverse variance; Std., standard.
Figure 5Forest plot showing the effects of supervised exercise training compared with usual care on changes in quality of life (short-form health survey: physical component summary). CI, confidence interval; IV, inverse variance; Std., standard.
Figure 6Forest plot showing the effects of supervised exercise training compared with usual care on changes in quality of life (short-form health survey: mental component summary). CI, confidence interval; IV, inverse variance; Std., standard.
Summary of risk of bias assessment
| Studies | The Cochrane Collaboration Tool | TESTEX | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other sources of bias | Total score (/15) | Study quality score (/5) | Study reporting score (/10) | |
| Akiba | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 4 | 1 | 3 |
| Carmack | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 6 | 3 | 4 |
| Carney | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 7 | 3 | 5 |
| Cheema | Low bias | Low bias | High bias | High bias | Low bias | Low bias | Unclear | 10 | 3 | 7 |
| Chen | Unclear | Low bias | High bias | Low bias | High bias | High bias | Low bias | 13 | 4 | 8 |
| de Lima | Low bias | Low bias | Unclear | Unclear | High bias | Unclear | Low bias | 9 | 4 | 5 |
| Deligiannis | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 6 | 3 | 4 |
| DePaul | Low bias | Low bias | High bias | Low bias | Low bias | Unclear | Unclear | 10 | 4 | 6 |
| Dobsak | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 6 | 1 | 5 |
| Dong | Low bias | Low bias | Unclear | Unclear | Low bias | Low bias | Low bias | 9 | 4 | 5 |
| Giannaki | Unclear | Low bias | High bias | Unclear | Unclear | Low bias | Unclear | 10 | 3 | 7 |
| Giannaki | Unclear | Unclear | High bias | Unclear | Low bias | Low bias | Unclear | 7 | 3 | 5 |
| Goldberg | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 4 | 1 | 3 |
| Goldberg | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 5 | 1 | 4 |
| Groussard | Unclear | Unclear | High bias | Unclear | Unclear | Unclear | Low bias | 6 | 3 | 4 |
| Guadalupe | Low bias | Low bias | Low bias | Low bias | Unclear | Unclear | Low bias | 10 | 5 | 5 |
| Johansen | Unclear | Low bias | Unclear | Unclear | Unclear | Unclear | Unclear | 9 | 3 | 7 |
| Kirkman | Unclear | Unclear | High bias | Unclear | Unclear | Low bias | Low bias | 7 | 3 | 5 |
| Koh | Low bias | Low bias | High bias | High bias | High bias | High bias | Low bias | 10 | 4 | 6 |
| Konstantinidou | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 8 | 3 | 6 |
| Koufaki | Low bias | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 9 | 3 | 6 |
| Kouidi | Low bias | Unclear | Unclear | Low bias | Unclear | Low bias | Low bias | 13 | 4 | 8 |
| Kouidi | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 8 | 3 | 6 |
| Matsufuji | Low bias | Low bias | Unclear | Unclear | High bias | Low bias | Unclear | 8 | 4 | 4 |
| Matsumoto | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 7 | 3 | 5 |
| Molsted | Low bias | Unclear | Unclear | Low bias | Unclear | Unclear | Unclear | 10 | 4 | 6 |
| Ouzouni | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 8 | 3 | 6 |
| Painter | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 7 | 3 | 5 |
| Parsons | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 6 | 3 | 4 |
| Pellizzaro | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Low bias | 8 | 3 | 6 |
| Petraki | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 7 | 3 | 5 |
| Reboredo | Unclear | Unclear | Unclear | Unclear | Unclear | Low bias | Unclear | 8 | 3 | 6 |
| Roboredo | Unclear | Unclear | Unclear | Unclear | Unclear | Low bias | Low bias | 7 | 3 | 5 |
| Segura-Orti | Low bias | Unclear | Low bias | Low bias | Unclear | Unclear | Unclear | 11 | 3 | 8 |
| Song and Sohng (2012) | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 7 | 3 | 5 |
| Tsuyuki | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | 3 | 1 | 1 |
| van Vilsteren | Unclear | Unclear | Unclear | Unclear | High bias | Unclear | Low bias | 8 | 1 | 7 |
| Wilund | Unclear | Unclear | Unclear | Low bias | High bias | Unclear | Low bias | 9 | 3 | 6 |
| Wu | Low bias | Low bias | Unclear | Unclear | Unclear | Unclear | Low bias | 10 | 4 | 6 |
TESTEX, Tool for the assEssment of Study qualiTy and reporting in Exercise.
Figure 7Funnel plot test exploring publication bias (exercise tolerance: peak/maximum oxygen consumption).
Figure 8Funnel plot test exploring publication bias (walking ability: 6-minute walk distance).